Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
108.13
(
0.61%
)
Bitcoin
76,932.38
(
-0.61%
)
News Focus
News Focus
Post# of 826537
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biosectinvestor

Send PM Follow Ignore
Followers 202
Posts 25627
Boards Moderated 0
Alias Born 04/03/2010

biosectinvestor

Re: sentiment_stocks post# 696547

Thursday, 06/06/2024 1:17:25 PM

Thursday, June 06, 2024 1:17:25 PM

Post# of 826537
They have orphaned status with the EU:

“Orphan drug designation number EU/3/07/431”

The UK does not automatically extend it post Brexit, but the PIM status was a very important designation and they likely asked for it in the Marketing Application, which is where they would now seek to get it post Brexit, given their past status.

I would expect it is likely they would get it. Doesn’t matter if it treats broader indications, for the indication that is orphaned, they should be able to get it and it should be possible to apply to both nGBM and rGBM

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News